Literature DB >> 30771379

The role of type I interferons in CD4+ T cell differentiation.

Mirela Kuka1, Marco De Giovanni1, Matteo Iannacone2.   

Abstract

Type I interferons (IFNs) released upon viral infections play different and opposing roles in disease outcome. This pleiotropic effect is mainly influenced by the cellular sources, timing and target cells for these molecules. The effect of type I IFN signaling on the activation and differentiation of antiviral CD4+ T cells remains ill defined, with studies reporting either a beneficial or a detrimental role, depending on the context of infection. This review will highlight several recent studies that have investigated the role of type I IFNs in the priming and polarization of CD4+ T cells and discuss areas of uncertainty that require further investigation.
Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CD4(+) T cell; T cell differentiation; T follicular helper cells; Th1; Type I interferons; Viral infection

Mesh:

Substances:

Year:  2019        PMID: 30771379      PMCID: PMC7234836          DOI: 10.1016/j.imlet.2019.01.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  54 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Competitive coexistence in antiviral immunity.

Authors:  R A Arnaout; M A Nowak
Journal:  J Theor Biol       Date:  2000-06-07       Impact factor: 2.691

3.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

4.  IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFN-gamma production by CD8 T cells after Listeria monocytogenes infection.

Authors:  Sing Sing Way; Colin Havenar-Daughton; Ganesh A Kolumam; Nural N Orgun; Kaja Murali-Krishna
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

Review 5.  In vivo imaging of adaptive immune responses to viruses.

Authors:  Marco De Giovanni; Matteo Iannacone
Journal:  Curr Opin Virol       Date:  2017-12-26       Impact factor: 7.090

Review 6.  Type I Interferon in Chronic Virus Infection and Cancer.

Authors:  Laura M Snell; Tracy L McGaha; David G Brooks
Journal:  Trends Immunol       Date:  2017-05-31       Impact factor: 16.687

7.  IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation.

Authors:  Ozen Sercan; Diana Stoycheva; Günter J Hämmerling; Bernd Arnold; Thomas Schüler
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

8.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

9.  Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.

Authors:  Arunakumar Gangaplara; Craig Martens; Eric Dahlstrom; Amina Metidji; Ameya S Gokhale; Deborah D Glass; Maria Lopez-Ocasio; Rachel Baur; Kishore Kanakabandi; Stephen F Porcella; Ethan M Shevach
Journal:  PLoS Pathog       Date:  2018-04-19       Impact factor: 6.823

Review 10.  Type I interferons in viral control and immune regulation.

Authors:  John R Teijaro
Journal:  Curr Opin Virol       Date:  2016-01-24       Impact factor: 7.090

View more
  6 in total

1.  Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer.

Authors:  Shingo Tsuji; Katherine Reil; Kinsey Nelson; Veronica H Proclivo; Kathleen L McGuire; Matthew J Giacalone
Journal:  Cancer Immunol Res       Date:  2022-08-03       Impact factor: 12.020

2.  A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection.

Authors:  Panpan Hou; Kongxiang Yang; Penghui Jia; Lan Liu; Yuxin Lin; Zibo Li; Jun Li; Shuliang Chen; Shuting Guo; Ji'An Pan; Junyu Wu; Hong Peng; Weijie Zeng; Chunmei Li; Yingfang Liu; Deyin Guo
Journal:  Cell Res       Date:  2020-07-01       Impact factor: 25.617

Review 3.  SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Authors:  Caio Henrique Mazucanti; Josephine Mary Egan
Journal:  Immun Ageing       Date:  2020-06-30       Impact factor: 6.400

Review 4.  Type I Interferon Production of Plasmacytoid Dendritic Cells under Control.

Authors:  Dóra Bencze; Tünde Fekete; Kitti Pázmándi
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

5.  The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways.

Authors:  Parakkal Jovvian George; Radu Marches; Djamel Nehar-Belaid; Jacques Banchereau; Sara Lustigman
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 6.  Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across.

Authors:  An-Katrien Minnaert; Helena Vanluchene; Rein Verbeke; Ine Lentacker; Stefaan C De Smedt; Koen Raemdonck; Niek N Sanders; Katrien Remaut
Journal:  Adv Drug Deliv Rev       Date:  2021-07-26       Impact factor: 17.873

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.